These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15905740)

  • 1. Potential deterrent effect of name-based HIV infection surveillance.
    Charlebois ED; Maiorana A; McLaughlin M; Koester K; Gaffney S; Rutherford GW; Morin SF
    J Acquir Immune Defic Syndr; 2005 Jun; 39(2):219-27. PubMed ID: 15905740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV surveillance in theory and practice: assessing the acceptability of California's non-name HIV surveillance regulations.
    Koester KA; Maiorana A; Vernon K; Charlebois E; Gaffney S; Lane T; Morin SF
    Health Policy; 2006 Aug; 78(1):101-10. PubMed ID: 16256243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does HIV reporting by name deter testing? MESH Study Group.
    Hecht FM; Chesney MA; Lehman JS; Osmond D; Vranizan K; Colman S; Keane D; Reingold A; Bindman AB
    AIDS; 2000 Aug; 14(12):1801-8. PubMed ID: 10985318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV testing behaviors and attitudes after adoption of name-to-code HIV case surveillance in Washington State.
    Hopkins SG; Gelfand SE; Buskin SE; Kent JB; Kahle EM; Barkan SE
    J Public Health Manag Pract; 2005; 11(1):25-8. PubMed ID: 15692289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National HIV reporting: what's in a name?
    Moayery S
    Va J Soc Policy Law; 2001; 8(2):439-73. PubMed ID: 16538748
    [No Abstract]   [Full Text] [Related]  

  • 6. Does name-based HIV reporting deter high-risk persons from HIV testing? Results from San Francisco.
    Schwarcz S; Stockman J; Delgado V; Scheer S
    J Acquir Immune Defic Syndr; 2004 Jan; 35(1):93-6. PubMed ID: 14707799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Name-based surveillance and public health interventions for persons with HIV infection. Multistate Evaluation of Surveillance for HIV Study Group.
    Osmond DH; Bindman AB; Vranizan K; Lehman JS; Hecht FM; Keane D; Reingold A
    Ann Intern Med; 1999 Nov; 131(10):775-9. PubMed ID: 10577302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health benefits and risks of reporting HIV-infected individuals by name.
    Colfax GN; Bindman AB
    Am J Public Health; 1998 Jun; 88(6):876-9. PubMed ID: 9618612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of HIV reporting by name on use of HIV testing in publicly funded counseling and testing programs.
    Nakashima AK; Horsley R; Frey RL; Sweeney PA; Weber JT; Fleming PL
    JAMA; 1998 Oct; 280(16):1421-6. PubMed ID: 9801002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. California nearing decision on reporting by coded ID.
    AIDS Policy Law; 1998 Sep; 13(16):7. PubMed ID: 11365745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mandatory name reporting of HIV infection.
    Bloomer S
    J Assoc Nurses AIDS Care; 1998; 9(6):80-1. PubMed ID: 9805299
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of name-based reporting and partner notification on HIV testing in New York State.
    Tesoriero JM; Battles HB; Heavner K; Leung SY; Nemeth C; Pulver W; Birkhead GS
    Am J Public Health; 2008 Apr; 98(4):728-35. PubMed ID: 18356570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. California lawmakers approve HIV reporting using coded IDs.
    AIDS Policy Law; 1998 Sep; 13(17):1, 6. PubMed ID: 11365747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Return rates and partner notification in HIV-positive men seeking anonymous versus confidential antibody testing.
    Berger SG; Hong BA; Eldridge S; Connor D; Vedder KN
    AIDS Patient Care STDS; 1999 Jun; 13(6):363-8. PubMed ID: 10842857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Name-based reporting of HIV-positive test results as a deterrent to testing.
    Woods WJ; Dilley JW; Lihatsh T; Sabatino J; Adler B; Rinaldi J
    Am J Public Health; 1999 Jul; 89(7):1097-100. PubMed ID: 10394324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illinois to conduct two-year experiment with coded IDs.
    AIDS Policy Law; 1998 Oct; 13(19):3. PubMed ID: 11365951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New approaches to HIV surveillance: means and ends. Summary report of conference held at Yale University, 21-22 May 1998, by the Law, Policy and Ethics Core, Center for Interdisciplinary Research on AIDS, Yale University.
    Johri M; Kaplan EH; Levi J; Novick A
    AIDS Public Policy J; 1999; 14(4):136-46. PubMed ID: 11148944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial of anonymous versus confidential human immunodeficiency virus testing.
    Fehrs LJ; Fleming D; Foster LR; McAlister RO; Fox V; Modesitt S; Conrad R
    Lancet; 1988 Aug; 2(8607):379-82. PubMed ID: 2899784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.
    Blair JM; McNaghten AD; Frazier EL; Skarbinski J; Huang P; Heffelfinger JD
    MMWR Surveill Summ; 2011 Sep; 60(11):1-20. PubMed ID: 21881551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concerns about article on code-versus-name reporting of HIV.
    Frye DM; Bunch G; Bingham T; Fielding J
    J Acquir Immune Defic Syndr; 2006 Oct; 43(2):249-50. PubMed ID: 17003674
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.